AKT1 and endometrial carcinoma: In summary, our results demonstrated that FBXL16 promoted MPA resistance of Ishikawa cell by PP2AB55α interaction and AKT1/GSK3β/cyclin D1 pathway in endometrial carcinoma, while knockdown of FBXL16 can reverse the MPA resistance of Ishikawa.